First performance report of QIAreach™ Anti-SARS-CoV-2 Total Test, an innovative nanoparticle fluorescence digital detection platform

In 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic. Disease diagnosis, appropriate clinical management and infection control are all important factors in controlling the spread of SARS-CoV-2. The QIAreach™ Anti-SARS-CoV-2 Total Test (Anti-CoV2) is a rapid,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stieber, Francis, Howard, Jenny, Rao, Sonia N., Kawamura, L. Masae, Manissero, Davide, Love, Joanna, Yang, Mei, Uchiyama, Robin, Parsons, Sean, Miller, Chris, Douwes, Harmony, McDonald, Aaron, Fairburn, Luke, Boyle, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833412/
https://www.ncbi.nlm.nih.gov/pubmed/33160178
http://dx.doi.org/10.1016/j.jcv.2020.104681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833412/
https://www.ncbi.nlm.nih.gov/pubmed/33160178
http://dx.doi.org/10.1016/j.jcv.2020.104681

Ejemplares similares